MHRA Safety Roundup: July 2025

View as a webpage / Share

MHRA Banner 2025 logo

MHRA Safety Roundup

July 2025


MHRA Safety Roundup: July 2025

This month's Safety Roundup includes: 

  • Drug Safety Update on Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults 
  • Device Safety Information on Aurum pre-filled syringes - phased introduction of new 10ml CONNECT syringe barrel: Importance of selecting compatible needle-free connectors to minimise the risk of syringe blockage
  • Device Safety Information on Trinity Biotech Premier Hb9210™ HbA1c Analyser: Risk of Positive Bias and Updates to Instructions for Use (IFU), including use as a diagnostic aid in diabetes mellitus
  • Device Safety Information on Updated guidance on the management of the recalled Endologix Nellix EndoVascular Aneurysm Sealing System 
  • Letters, medicines recalls and device notifications sent to healthcare professionals in June and July 2025 
  • News on:
    • Contamination of non-sterile alcohol-free skin cleansing wipes - actions for healthcare professionals

    • Passy Muir speaking valve (PMV) - reminder of safe management after incident reports

    • Yellow Card Biobank recruiting patients taking GLP-1’s and experiencing acute pancreatitis

    • Publication of fluoroquinolone antibiotics Public Assessment Report (PAR)

    • Launch of MHRA medical device survey – Have your say 

July's Safety Roundup is now available to read as a downloadable document or on the GOV.UK website


It's easy to report

Report a suspected adverse drug reaction online
or download the Yellow Card app

REPORT ONLINE


Thank you,

The Medicines and Healthcare products Regulatory Agency

MHRA TwitterMHRA FacebookMHRA LinkedInMHRA YouTubeMHRA Inspectorate blog